Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Gut
|
October 16, 2019
Immune checkpoint inhibitors: use them early, combined and instead of TACE?
Enrico N De Toni
Gut
|
February 14, 2020
Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma
Enrico N De Toni, Daniel Roessler
United European Gastroenterology Journal
|
September 20, 2018
Use of checkpoint inhibitors in liver transplant recipients
Stefan Munker, Enrico N De Toni
Gastroenterology
|
April 7, 2017
Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient
Enrico N De Toni, Alexander L Gerbes
Clinical and Translational Gastroenterology
|
September 21, 2020
Response to Chen et al
Liangtao Ye, Florian P Reiter, Markus Guba, et al.
Deutsches Arzteblatt International
|
April 4, 2019
Checkpoint Inhibitors
Lucie Heinzerling, Enrico N de Toni, Georg Schett, et al.
Case Reports in Oncology
|
July 20, 2011
Contrast-enhanced ultrasound for surveillance of choroidal carcinoma patients: features of liver metastasis arising several years after treatment of the primary tumor
Enrico N De Toni, Eike Gallmeier, Christoph J Auernhammer, et al.
JHEP Reports : Innovation in Hepatology
|
August 6, 2024
Response to: "Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC"
Najib Ben Khaled, Julia Mayerle, Enrico N De Toni, et al.
The American Journal of Gastroenterology
|
August 28, 2020
Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment
Liangtao Ye, Changhua Zhang, Max Seidensticker, et al.
Gastro Hep Advances
|
August 12, 2024
Worldwide Incidence and Mortality of Biliary Tract Cancer
Katherine Baria, Enrico N De Toni, Binbing Yu, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Gut
|
October 16, 2019
Immune checkpoint inhibitors: use them early, combined and instead of TACE?
Enrico N De Toni
Gut
|
February 14, 2020
Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma
Enrico N De Toni, Daniel Roessler
United European Gastroenterology Journal
|
September 20, 2018
Use of checkpoint inhibitors in liver transplant recipients
Stefan Munker, Enrico N De Toni
Gastroenterology
|
April 7, 2017
Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient
Enrico N De Toni, Alexander L Gerbes
Clinical and Translational Gastroenterology
|
September 21, 2020
Response to Chen et al
Liangtao Ye, Florian P Reiter, Markus Guba, et al.
Deutsches Arzteblatt International
|
April 4, 2019
Checkpoint Inhibitors
Lucie Heinzerling, Enrico N de Toni, Georg Schett, et al.
Case Reports in Oncology
|
July 20, 2011
Contrast-enhanced ultrasound for surveillance of choroidal carcinoma patients: features of liver metastasis arising several years after treatment of the primary tumor
Enrico N De Toni, Eike Gallmeier, Christoph J Auernhammer, et al.
JHEP Reports : Innovation in Hepatology
|
August 6, 2024
Response to: "Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC"
Najib Ben Khaled, Julia Mayerle, Enrico N De Toni, et al.
The American Journal of Gastroenterology
|
August 28, 2020
Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment
Liangtao Ye, Changhua Zhang, Max Seidensticker, et al.
Gastro Hep Advances
|
August 12, 2024
Worldwide Incidence and Mortality of Biliary Tract Cancer
Katherine Baria, Enrico N De Toni, Binbing Yu, et al.
Page
of 13